ciprofloxacin and vitamin k 3

ciprofloxacin has been researched along with vitamin k 3 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goswami, M; Jawali, N; Mangoli, SH1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chung, TT; Collin, F; Greive, SJ; Karkare, S; Lall, N; Maxwell, A; McKay, AR; Meyer, JJ; Mitchenall, LA1

Other Studies

3 other study(ies) available for ciprofloxacin and vitamin k 3

ArticleYear
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Catalase; Escherichia coli; Glutathione; Indicators and Reagents; Nitroblue Tetrazolium; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Streptomycin; Superoxide Dismutase

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
    The Journal of biological chemistry, 2013, Feb-15, Volume: 288, Issue:7

    Topics: Adenosine Triphosphate; Anti-Infective Agents; Binding Sites; Catalytic Domain; DNA; DNA Gyrase; Escherichia coli; Humans; Inhibitory Concentration 50; Mass Spectrometry; Models, Chemical; Mycobacterium tuberculosis; Naphthoquinones; Protein Binding; Protein Structure, Tertiary; Staphylococcus aureus; Surface Plasmon Resonance; Tuberculosis

2013